XmAb-14484

N/A

Report date: 2026/03/19 16:57:20

Base Information

Drug NameXmAb-14484
Drug Alias NameXmAb-19722anti-CD3/anti-PSMA bispecific T-cell engager (Xencor)anti-PSMA x anti-CD3 bispecific antibodies (Xencor)affinity tuned XmAb 2+1 anti-PSMA x anti-CD3 bispecific antibodies (Xencor)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionProstate-Specific Membrane Antigen modulatorsT cell surface glycoprotein CD3 modulators
TargetsProstate-Specific Membrane AntigenT cell surface glycoprotein CD3
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXencor Inc
China Registration ClassN/A

Develop Information

Active CompaniesXencor Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A